Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care Settings
Key facts
- Who runs it
- Zhujiang Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 216 people enrolled
- Started
- 17 Dec 2024
- Ended
- 30 Jun 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- Wet Blood Gas Analyzer (ABL90)
- Dry Blood Gas Analyzer (EG-i30)
- Record updated
- 18 July 2025
Who can take part
- Age
- 28 days and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients who are scheduled to undergo arterial blood gas analysis in the emergency department (ED) or emergency intensive care unit (EICU)
Who cannot take part
- Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV/AIDS, etc
- Patients whose residual blood samples are not tested within the specified time frame after collection
- Other patients deemed ineligible by the investigator (e.g., samples with contamination or other factors affecting sample quality)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to validate the performance of the novel POCT dry blood gas analyzer EG-i30, against the currently widely used traditional wet blood gas analyzer, Radiometer ABL90, in acute care settings. The main questions it aims to answer are:
Read full original descriptionShow less
1. How consistent are the results between EG-i30 and ABL90 in acute care settings, including outliers, correlation, linearity, and bias? 2. Whether EG-i30 can be considered a suitable alternative to ABL90 in acute care settings.
Participants will be patients in the emergency department who will undergo simultaneous testing with EG-i30 and ABL90 during their emergency care to assess the performance of EG-i30.
The 2 groups in the trial
- Group 1: ABL90 Group
Blood gas and biochemical measurements are performed using the ABL90 blood gas analyzer. The results will be compared with those from the EG-i30 analyzer.
Treatment: Wet Blood Gas Analyzer (ABL90)
- Group 2: EG-i30 Group
Blood gas and biochemical measurements are performed using the EG-i30 blood gas analyzer. The results will be compared with those from the ABL90 analyzer.
Treatment: Dry Blood Gas Analyzer (EG-i30)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care Settings:A Cross-Sectional Study
- Record updated
- 18 July 2025